Federated Hermes
MXCT icon

Federated Hermes’s MaxCyte MXCT Stock Holding History

Federated Hermes’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,003
Closed -$705 – 2131
2026
Q1 		$705 Buy
+1,003
New +$936 ﹤0.01% 2020
2024
Q4 		– Sell
-9,736
Closed -$37.9K – 2154
2024
Q3 		$37.9K Buy
9,736
+4,110
+73% +$17.3K ﹤0.01% 1696
2024
Q2 		$22.1K Sell
5,626
-1,114
-17% -$4.79K ﹤0.01% 1710
2024
Q1 		$28.2K Buy
+6,740
New +$31.6K ﹤0.01% 1687
2022
Q4 		– Sell
-3,448
Closed -$22K – 2235
2022
Q3 		$22K Buy
3,448
+1,223
+55% +$6.82K ﹤0.01% 1761
2022
Q2 		$11K Sell
2,225
-986,002
-100% -$4.86M ﹤0.01% 1822
2022
Q1 		$6.91M Sell
988,227
-349
-0% -$2.38K 0.02% 701
2021
Q4 		$10.1M Buy
988,576
+295,986
+43% +$3.18M 0.02% 642
2021
Q3 		$8.46M Buy
+692,590
New +$10.4M 0.02% 694

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Federated Hermes's MXCT Position: Q2 2026 in Review

Federated Hermes sold out of MaxCyte (MXCT) in Q2 2026, closing a stake of 1,003 shares — an estimated $705 sold.

Federated Hermes first reported a position in MXCT in Q3 2021 and held it in 9 quarters. The position peaked at $10.1M in Q4 2021. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Federated Hermes reported no remaining MaxCyte position as of Q2 2026 after selling out during the quarter.
  • Federated Hermes sold 1,003 MaxCyte shares in Q2 2026, an estimated $705.
  • Federated Hermes first reported a position in MaxCyte in Q3 2021 and held it in 9 quarters.
  • Federated Hermes's MaxCyte position peaked at $10.1M in Q4 2021.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.